| Dianne Watters1, Kum Kum Khanna1, Heather Beamish1, Geoffrey Birrell1, Kevin Spring1, Padmini Kedar1, Magtouf Gatei1, Deborah Stenzel2, Karen Hobson1, Sergei Kozlov1, Ning Zhang1, Aine Farrell1, Jonathan Ramsay3, Richard Gatti4 and Martin Lavin5,a |
1The Queensland Cancer Fund Research Unit, Queensland Institute of Medical Research, P.O. Royal Brisbane Hospital, Herston, Brisbane 4029, Australia
2Analytical Electron Microscope Facility, Queensland University of Technology, Gardens Point, George Street, Brisbane, 4000, Australia
3Queensland Radium Institute, Royal Brisbane Hospital, Herston Road, Brisbane 4029, Australia
4Department of Pathology, Centre for Health Sciences, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, USA
5Department of Surgery, University of Queensland, Royal Brisbane Hospital, Herston, Brisbane 4029, Australia
|
The recently cloned gene (ATM) mutated in the human genetic disorder ataxia-telangiectasia (A-T) is involved in DNA damage response at different cell cycle checkpoints and also appears to have a wider role in signal transduction. Antibodies prepared against peptides from the predicted protein sequence detected a ~ 350 kDa protein corresponding to the open reading frame, which was absent in 13/23 A-T homozygotes. Subcellular fractionation, immunoelectronmicroscopy and immunofluorescence showed that the ATM protein is present in the nucleus and cytoplasmic vesicles. This distribution did not change after irradiation. We also provide evidence that ATM protein binds to p53 and this association is defective in A-T cells compatible with the defective p53 response in these cells. These results provide further support for a role for the ATM protein as a sensor of DNA damage and in a more general role in cell signalling, compatible with the broader phenotype of the syndrome. |